Zobrazeno 1 - 10
of 10
pro vyhledávání: '"BURCU YAPAR TAŞKÖYLÜ"'
Autor:
Melek ÖZDEMİR, Gamze GÖKOZ DOĞU, Burcu YAPAR TAŞKÖYLÜ, Atike Gökçen DEMİRAY, Burçin ÇAKAN DEMİREL, Tolga DOĞAN, Taliha GÜÇLÜ KANTAR, Arzu YAREN, Serkan DEĞİRMENCİOĞLU, Semra TAŞ, Bedriye AÇIKGÖZ YILDIZ, Gamze Serin ÖZEL
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 12, Iss 3, Pp 155-162 (2024)
Aim: According to the information obtained from the World Health Organization database, the incidence of hepatocellular carcinoma (HCC) in Turkey increased by 17.78% between the years of 2018 and 2020. In this study, we investigated the prognostic va
Externí odkaz:
https://doaj.org/article/991712c2587e49699349f14a0eeb8977
Autor:
Atike Gökçen Demiray, Arzu Yaren, Uğur Sungurtekin, Papatya Bahar Baltalarlı, Neşe Demirkan, Duygu Herek, Burcu Yapar Taşköylü, Gamze Gököz Doğu, Serkan Değirmencioğlu, Utku Özgen, Halil Sağınç, Umut Çakıroğlu, Nail Özhan, Canan Karan, Burçin Çakan Demirel, Tolga Doğan, Melek Özdemir
Publikováno v:
Journal of Oncology. 2022:1-8
Aim. The current standard treatment of locally advanced rectal carcinoma is total mesorectal excision and postoperative adjuvant chemotherapy after neoadjuvant concurrent chemoradiotherapy (NCRT). Many studies have shown that pathological complete re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b612e4fb8a71b3899a9c45ea1ada4a3
https://doi.org/10.1155/2022/4108677
https://doi.org/10.1155/2022/4108677
Autor:
Tolga DOĞAN, Arzu YAREN, Atike Gökçen DEMİRAY, Burcu YAPAR TAŞKÖYLÜ, Burçin ÇAKAN DEMİREL, Melek ÖZDEMİR, Taliha GÜÇLÜ KANTAR, Serkan DEĞİRMENCİOĞLU, Gamze GOKOZ DOGU
Publikováno v:
Pamukkale Medical Journal.
Purpose:We evaluated the effect of pre-treatment inflammation response markers on overall survival (OS) and progression-free survival (PFS) in patients with locally advanced unresectable and metastatic gastric cancer. Material and Method:Patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a28486ae180e30cbcb45c05bad81fb5
https://doi.org/10.31362/patd.1265291
https://doi.org/10.31362/patd.1265291
Autor:
Halil SAĞINÇ, Burcu YAPAR TAŞKÖYLÜ
Publikováno v:
Volume: 16, Issue: 1 81-88
Pamukkale Medical Journal
Pamukkale Tıp Dergisi
Pamukkale Medical Journal
Pamukkale Tıp Dergisi
Amaç: Kanserden korunma ve erken tarama programlarının farkındalığını arttırmak için sağlık çalışanlarına planlı eğitiminin etkisini araştırmaktır. Gereç ve Yöntem: Kanser erken tanı eğitimimizde kanserden korunma ve erken ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d85eb5cda1ddbadd7f780585bd8e03c7
https://dergipark.org.tr/tr/pub/patd/issue/71515/1170681
https://dergipark.org.tr/tr/pub/patd/issue/71515/1170681
Autor:
Atike Gökçen Demiray, Arzu Yaren, Burcu Yapar Taşköylü, Serkan Değirmencioğlu, Gamze Gököz Doğu
Publikováno v:
Dicle Medical Journal, Vol 48, Iss 1, Pp 163-170 (2021)
Objective: Glioblastoma Multiforme (GBM) is the most common primary malignant brain tumor in adults. Optimal treatment is adjuvant concomitant chemoradiotherapy following the widest possible surgical resection (maximum safe resection) followed by adj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::2cffb09d35db5ed48c6fbd6e92fe2832
Autor:
Atike Gökçen, Demiray, Aydın, Demiray, Arzu, Yaren, Burcu, Yapar Taşköylü, Gamze, Gököz Doğu, Serkan, Değirmencioğlu, Umut, Çakıroğlu, Nail, Özhan, Canan, Karan, Burçin, Çakan Demirel, Tolga, Doğan, Melek, Özdemir
Background: First-line treatments for metastatic pancreatic cancer are chemotherapy regimens consisting of 5-fluorouracil or gemcitabine; however, there are no biomarkers to help determine which patients might benefit from which treatment regimens. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f50b3f78a5824ee343005db969330e4
https://doi.org/10.5152/tjg.2022.21829
https://doi.org/10.5152/tjg.2022.21829
Autor:
BURCU YAPAR TAŞKÖYLÜ, GÜZİN FİDAN YAYLALI, Gamze GÖKÖZ DOĞU, ATİKE GÖKÇEN DEMİRAY, SERKAN DEĞİRMENCİOĞLU, AHMET ERGİN
Objectives: Megestrol acetate (MA) can induce significant secondary adrenal suppression. We designed this study todetermine the extent of adrenal insufficiency in cancer patients receiving MA and whether ther was any predictivefactor for this.Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::5346a7802b671f3999c53514643c3cce
Objectives: The aim of our study is reducing the healthcare workers’ duration of exposure to the cytotoxic agentswithout increasing the unused dose wasting during preparation by making changes in vial sizes of cytotoxic drugs.Methods: Wasted doses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::2713bc02a775fb38ec5e075e73d371f4
Autor:
SERKAN DEĞİRMENCİOĞLU, ÖZGÜR TANRIVERDİ, ESİN OKTAY, ESİN AVCI, ATİKE GÖKÇEN DEMİRAY, HANDE ŞENOL, BURCU YAPAR TAŞKÖYLÜ, Gamze GÖKÖZ DOĞU, Arzu YAREN
Objectives: Lung cancer is the most common cause of cancer-related deaths worldwide. The use of tobacco and tobacco products is among the leading risk factors with proven association with lung cancer, although various environmental and dietary factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::4cb83a39fca5a47384afe8677bfe0fc9
Autor:
Tarik Sengoz, Yeliz Arman Karakaya, Aziz Gültekin, Sevda Yilmaz, Ergun Erdem, Burcu Yapar Taskoylu, Zehra Kesen, Olga Yaylali, Dogangun Yuksel
Publikováno v:
European Journal of Breast Health, Vol 19, Iss 2, Pp 159-165 (2023)
Objective:The role of baseline and post-treatment standardized uptake value (SUVmax) values in predicting pathological response in patients with breast cancer after neoadjuvant chemotherapy (NAC).Materials and Methods:Thirty patients with invasive du
Externí odkaz:
https://doaj.org/article/03cf989f1c3e4121a8be5499ea7e46fe